DIA Daily | Experimental Drug May Reduce Brain Plaques
Experimental Drug May Reduce Brain Plaques, Slow Progression Of Dementia, Study Suggests
The New York Times
The New York Times(7/25, Belluck) reports, “The long-elusive quest for a medication that works to treat Alzheimer’s reached a potentially promising milestone” yesterday. According to the Times, “for the first time in a large clinical trial, a drug was able to both reduce the plaques in the brains of patients and slow the progression of dementia.”
相关链接：
http://mailview.bulletinhealthcare.com/mailview.aspx?m=2018072601dia&r=7819783-82d7&l=007-e7f&t=c
Wall Street Journal
The Wall Street Journal(7/25, Loftus, Subscription Publication) reports that the findings on the drug, known as BAN2401, were presented at the Alzheimer’s Association International Conference.
相关链接：
http://mailview.bulletinhealthcare.com/mailview.aspx?m=2018072601dia&r=7819783-82d7&l=008-2ff&t=c
Reuters
Reuters(7/25, Steenhuysen) reports that the drug’s developers, “Biogen Inc. and partner Eisai Co. Ltd., said patients with early-stage Alzheimer’s disease treated with their experimental drug...experienced 30 percent less cognitive decline than those who got a placebo.” Meanwhile, “the second-highest dose of the drug also showed some benefit, but did not meet statistical significance, according to” the data. Reuters adds, “BAN2401 demonstrated a dose-dependent reduction in amyloid plaques that was statistically significant at all doses tested, researchers said.”
相关链接：
http://mailview.bulletinhealthcare.com/mailview.aspx?m=2018072601dia&r=7819783-82d7&l=009-e4d&t=c
STAT
STAT(7/25, Garde) reports, “Biogen and Eisai have not said whether they will take up a larger study to tease out BAN2401’s benefits or go straight to the FDA with the Phase 2 results.”
相关链接：
http://mailview.bulletinhealthcare.com/mailview.aspx?m=2018072601dia&r=7819783-82d7&l=00a-e6d&t=c
DIA会员
▲点击图片了解详情
DIA NOW
▲点击图片了解详情
推荐阅读
关于DIA
DIA总部位于美国首都Washington DC，此外在北美、欧洲、日本、中国等设有分部。作为一家中立的国际组织，DIA 在制药和其它医疗健康领域，孜孜不倦50余年，为政府，工业和学术机构提供了形式多样的交流和学习的平台，赢得广泛认可和赞誉。
DIA是中国医药健康研发领域必不可缺的专业分享和知识更新的伙伴
DIA微信订阅号
全新上线 ！
DIA微信
订阅号
◀ 关注我
长按识别左侧二维码即可关注
我们努力为你提供有内容的内容。